{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T04:06:45Z","timestamp":1784088405378,"version":"3.55.0"},"reference-count":28,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes"],"abstract":"<jats:p>Background: Endometrial carcinoma (EC) is one of the most common gynaecological malignancies, with a steadily increasing incidence worldwide. In 2013, a novel molecular classification of ECs enabled patient stratification into four groups with important clinical management implications: (1) DNA Polymerase Epsilon (POLE)-mutated, (2) microsatellite instability-high (MSI-H\/dMMR) hypermutated, (3) tumours with low somatic copy number alteration (low-SCNA), and (4) tumours with high SCNA and p53 deficiency. This molecular classification should also be used as a tool to identify hereditary cancer syndromes, as MSI-ECs can be associated with Lynch Syndrome (LS, ORPHA:144) while somatic POLE mutations may reflect polymerase proofreading-associated polyposis (PPAP syndrome, ORPHA:447877). Methods: From 2022 to 2024, molecular classification of ECs was routinely performed on 188 consecutive cases. The results were correlated with family history and constitutional genetic testing. Results: Somatic testing revealed that 45 ECs were dMMR and 23 carried POLE variants. Five POLE-mutated ECs also displayed concomitant MSI. For all 68 patients, cancer genetic counselling was proposed, but only 41 accepted, and of these, 26 patients were eligible for the genetic test. None of the POLE somatic variants were proven to be constitutive, whereas LS was diagnosed in seven patients with dMMR-EC; interestingly, two of these patients displayed a POLE-mutated EC. Conclusions: Our data strongly suggest that molecular classification of ECs is important to improve the identification of LS and highlight the relevance of investigating all molecular markers at once in order to identify overlaps between POLE mutations and MMR defects.<\/jats:p>","DOI":"10.3390\/genes17070801","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T03:06:52Z","timestamp":1784084812000},"page":"801","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["From Molecular Classification to Hereditary Cancer Syndrome Identification in Endometrial Cancer"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2130-6669","authenticated-orcid":false,"given":"Laura","family":"Libera","sequence":"first","affiliation":[{"name":"Unit of Pathology, Ospedale di Circolo, ASST Sette Laghi, 21100 Varese, Italy"},{"name":"Hereditary Cancer Research Center, University of Insubria, 21100 Varese, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0511-5427","authenticated-orcid":false,"given":"Ileana","family":"Carnevali","sequence":"additional","affiliation":[{"name":"Hereditary Cancer Research Center, University of Insubria, 21100 Varese, Italy"},{"name":"SSD Specialized Laboratory of Medical Genetics, Cytogenetics and Molecular Genetics, ASST Sette Laghi, 21100 Varese, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Facchi","sequence":"additional","affiliation":[{"name":"Unit of Pathology, Ospedale di Circolo, ASST Sette Laghi, 21100 Varese, Italy"},{"name":"Hereditary Cancer Research Center, University of Insubria, 21100 Varese, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6227-8628","authenticated-orcid":false,"given":"Nora","family":"Sahnane","sequence":"additional","affiliation":[{"name":"Unit of Pathology, Ospedale di Circolo, ASST Sette Laghi, 21100 Varese, Italy"},{"name":"Hereditary Cancer Research Center, University of Insubria, 21100 Varese, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Travaglino","sequence":"additional","affiliation":[{"name":"Unit of Pathology, Ospedale di Circolo, ASST Sette Laghi, 21100 Varese, Italy"},{"name":"Unit of Pathology, Department of Medicine and Technological Innovation, University of Insubria, 21100 Varese, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"La Rosa","sequence":"additional","affiliation":[{"name":"Unit of Pathology, Ospedale di Circolo, ASST Sette Laghi, 21100 Varese, Italy"},{"name":"Hereditary Cancer Research Center, University of Insubria, 21100 Varese, Italy"},{"name":"Unit of Pathology, Department of Medicine and Technological Innovation, University of Insubria, 21100 Varese, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8471-1229","authenticated-orcid":false,"given":"Maria Grazia","family":"Tibiletti","sequence":"additional","affiliation":[{"name":"Hereditary Cancer Research Center, University of Insubria, 21100 Varese, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,14]]},"reference":[{"key":"ref_1","first-page":"7","article-title":"Cancer Statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","first-page":"394","article-title":"Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"ref_3","first-page":"7","article-title":"Cancer Statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"741","DOI":"10.3390\/curroncol29020063","article-title":"Endometrial Cancer: Transitioning from Histology to Genomics","volume":"29","author":"Mitric","year":"2022","journal-title":"Curr. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"The Cancer Genome Atlas Research Network, and Levine, D.A. (2013). Integrated Genomic Characterization of Endometrial Carcinoma. Nature, 497, 67\u201373.","DOI":"10.1038\/nature12113"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"17588359261425078","DOI":"10.1177\/17588359261425078","article-title":"An Intriguing Journey into the Hereditary Syndromes Predisposing to Endometrial Cancer: More than Believed","volume":"18","author":"Fanale","year":"2026","journal-title":"Ther. Adv. Med. Oncol."},{"key":"ref_7","unstructured":"WHO Classification of Tumours Editorial Board (2020). Female Genital Tumours [Internet], International Agency for Research on Cancer. [5th ed.]. Available online: https:\/\/tumourclassification.iarc.who.int\/chapters\/34."},{"key":"ref_8","unstructured":"(2026, May 28). The POLE Gene Homepage\u2014Global Variome Shared LOVD. Available online: https:\/\/databases.lovd.nl\/shared\/genes\/POLE."},{"key":"ref_9","unstructured":"(2026, June 30). The Human Genomics Community. Available online: https:\/\/varsome.com\/."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/path.5372","article-title":"Interpretation of Somatic POLE Mutations in Endometrial Carcinoma","volume":"250","author":"Britton","year":"2020","journal-title":"J. Pathol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00428-004-1090-5","article-title":"The Utility of Immunohistochemical Detection of DNA Mismatch Repair Gene Proteins","volume":"445","author":"Shia","year":"2004","journal-title":"Virchows Arch."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"155183","DOI":"10.1016\/j.prp.2024.155183","article-title":"Immunohistochemical and Molecular Pattern of P53 in Epithelial Ovarian Cancers Negative for Germline BRCA1\/2 Variants","volume":"255","author":"Ronchi","year":"2024","journal-title":"Pathol. Res. Pract."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/jnci\/djh034","article-title":"Revised Bethesda Guidelines for Hereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome) and Microsatellite Instability","volume":"96","author":"Umar","year":"2004","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"znae070","DOI":"10.1093\/bjs\/znae070","article-title":"Updated European Guidelines for Clinical Management of Familial Adenomatous Polyposis (FAP), MUTYH-Associated Polyposis (MAP), Gastric Adenocarcinoma, Proximal Polyposis of the Stomach (GAPPS) and Other Rare Adenomatous Polyposis Syndromes: A Joint EHTG-ESCP Revision","volume":"111","author":"Zaffaroni","year":"2024","journal-title":"Br. J. Surg."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"116739","DOI":"10.1016\/j.ejca.2026.116739","article-title":"ESGO Consensus Statement on Endometrial Cancer Prevention, Risk Reduction Strategies, and Management of Women with Lynch Syndrome","volume":"240","author":"Marchetti","year":"2026","journal-title":"Eur. J. Cancer"},{"key":"ref_17","unstructured":"(2026, May 28). InSiGHT. Available online: https:\/\/www.insight-group.org\/."},{"key":"ref_18","unstructured":"(2026, May 28). The POLD1 Gene Homepage\u2014Global Variome Shared LOVD. Available online: https:\/\/databases.lovd.nl\/shared\/genes\/POLD1."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/his.14015","article-title":"Incorporation of Molecular Characteristics into Endometrial Cancer Management","volume":"76","author":"Vermij","year":"2020","journal-title":"Histopathology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/ijgc-2020-002230","article-title":"ESGO\/ESTRO\/ESP Guidelines for the Management of Patients with Endometrial Carcinoma","volume":"31","author":"Concin","year":"2021","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.humpath.2022.07.014","article-title":"Critical Aspects of Microsatellite Instability Testing in Endometrial Cancer: A Comparison Study","volume":"128","author":"Libera","year":"2022","journal-title":"Hum. Pathol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1136\/ijgc-2024-ESGO.442","article-title":"Clinicopathological Characteristics of Multiple-Classifier Endometrial Cancers: A Cohort Study and Systematic Review","volume":"34","author":"Schivardi","year":"2024","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/CEJ.0000000000000677","article-title":"Universal Testing for MSI\/MMR Status in Colorectal and Endometrial Cancers to Identify Lynch Syndrome Cases: State of the Art in Italy and Consensus Recommendations from the Italian Association for the Study of Familial Gastrointestinal Tumors (A.I.F.E.G.)","volume":"31","author":"Tibiletti","year":"2022","journal-title":"Eur. J. Cancer Prev."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"vi33","DOI":"10.1093\/annonc\/mdt353","article-title":"Endometrial Cancer: ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-Up","volume":"24","author":"Colombo","year":"2013","journal-title":"Ann. Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ygyno.2022.10.024","article-title":"Molecular Testing for Endometrial Cancer: An SGO Clinical Practice Statement","volume":"168","author":"Walsh","year":"2023","journal-title":"Gynecol. Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/ejhg.2010.216","article-title":"Concurrent Genetic Alterations in DNA Polymerase Proofreading and Mismatch Repair in Human Colorectal Cancer","volume":"19","author":"Yoshida","year":"2011","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s10689-021-00256-y","article-title":"The Clinical Features of Polymerase Proof-Reading Associated Polyposis (PPAP) and Recommendations for Patient Management","volume":"21","author":"Palles","year":"2022","journal-title":"Fam. Cancer"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13053-023-00263-3","article-title":"Dominantly Inherited Micro-Satellite Instable Cancer\u2014The Four Lynch Syndromes\u2014An EHTG, PLSD Position Statement","volume":"21","author":"Ahadova","year":"2023","journal-title":"Hered. Cancer Clin. Pract."}],"container-title":["Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4425\/17\/7\/801\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T03:25:27Z","timestamp":1784085927000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4425\/17\/7\/801"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,14]]},"references-count":28,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["genes17070801"],"URL":"https:\/\/doi.org\/10.3390\/genes17070801","relation":{},"ISSN":["2073-4425"],"issn-type":[{"value":"2073-4425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,14]]}}}